--- schema_version: "secwatch.filing_event.v1" accession: "0001193125-26-216710" form_type: "8-K" ticker: "GRTX" cik: "0001563577" company_name: "Galera Therapeutics, Inc." filed_at: "2026-05-11T20:02:33+00:00" generated_at: "2026-05-11T22:57:36.763038+00:00" event_type: "other_material" sentiment: "negative" materiality_score: 0.8 calibrated_materiality_score: 0.8 confidence: "high" source: SEC EDGAR --- # Galera shareholders approve reverse split (1:75 to 1:200) and share increase to 400M ## Summary - Elected J. Mel Sorensen (Class III), Nancy Chang and Michael Friedman (Class I) as directors. - Ratified KPMG as auditor for FY 2026. - Approved say-on-pay and annual frequency for future say-on-pay votes. - Authorized amendment raising common shares from 200M to 400M. - Authorized reverse stock split at Board-discretion ratio between 1:75 and 1:200. ## SEC filing metadata - accession: 0001193125-26-216710 - form_type: 8-K - ticker: GRTX - cik: 0001563577 - company_name: Galera Therapeutics, Inc. - filed_at: 2026-05-11T20:02:33+00:00 - event_type: other_material - sentiment: negative - materiality_score: 0.8 - calibrated_materiality_score: 0.8 - confidence: high - sec_items: 5.07 - EDGAR index: https://www.sec.gov/Archives/edgar/data/1563577/000119312526216710/0001193125-26-216710-index.htm - EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1563577/000119312526216710/d137690d8k.htm ## Machine-readable alternates - HTML: https://secwatch.observer/filing/0001193125-26-216710 - JSON: https://secwatch.observer/filing/0001193125-26-216710.json - Plain text: https://secwatch.observer/filing/0001193125-26-216710.txt ## Key facts - Shareholder Votes Galera Therapeutics, Inc. shareholders approved Advisory Vote on Frequency of Future Say-On-Pay Votes (every one year) at the 2026-05-08 meeting. - Proposal: say on pay frequency - Outcome: passed - Meeting: 2026-05-08 source text: Proposal 4—Advisory Vote on Frequency of Future Say-On-Pay Votes: 1 Year 2 Years 3 Years Abstentions Broker Non-Votes 108,127,837 64,666 3,611,866 1,076,074 10,877,949 evidence_url: https://www.sec.gov/Archives/edgar/data/1563577/000119312526216710/0001193125-26-216710-index.htm - Shareholder Votes Galera Therapeutics, Inc. shareholders approved Election of Directors at the 2026-05-08 meeting. - Proposal: director election - Outcome: passed - Meeting: 2026-05-08 source text: At the combined 2025 and 2026 Annual Meeting of Stockholders (the “ Annual Meeting ”) of Galera Therapeutics, Inc. (the “ Company ”) held on May 8, 2026, the Company’s stockholders (i) elected (A) one Class III director to the board of directors of the Company (the “ Board ”), to serve until the Company’s 2028 annual meeting of stockholders and until his successor is duly elected and qualified, and (B) two Class I directors to the Board, each to serve until the Company’s 2029 annual meeting of stockholders and until their respective successors are duly elected and qualified evidence_url: https://www.sec.gov/Archives/edgar/data/1563577/000119312526216710/0001193125-26-216710-index.htm - Shareholder Votes Galera Therapeutics, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-05-08 meeting. - Proposal: auditor ratification - Outcome: passed - Meeting: 2026-05-08 source text: Proposal 2—Ratification of Appointment of Independent Registered Public Accounting Firm: Votes For Votes Against Abstentions 121,742,195 1,961,191 55,006 evidence_url: https://www.sec.gov/Archives/edgar/data/1563577/000119312526216710/0001193125-26-216710-index.htm - Shareholder Votes Galera Therapeutics, Inc. shareholders approved Approval of Charter Amendment to Increase Authorized Capital Stock from 200 million shares to 400 million shares at the 2026-05-08 meeting. - Proposal: charter amendment - Outcome: passed - Meeting: 2026-05-08 source text: Proposal 5—Approval of Charter Amendment to Increase Authorized Capital Stock: Votes For Votes Against Abstentions 120,916,020 2,745,505 96,867 evidence_url: https://www.sec.gov/Archives/edgar/data/1563577/000119312526216710/0001193125-26-216710-index.htm - Shareholder Votes Galera Therapeutics, Inc. shareholders approved Approval of Charter Amendment to Provide Written Consent Right at the 2026-05-08 meeting. - Proposal: charter amendment - Outcome: passed - Meeting: 2026-05-08 source text: Proposal 6—Approval of Charter Amendment to Provide Written Consent Right: Votes For Votes Against Abstentions Broker Non-Votes 112,456,777 417,500 6,166 10,877,949 evidence_url: https://www.sec.gov/Archives/edgar/data/1563577/000119312526216710/0001193125-26-216710-index.htm - Shareholder Votes Galera Therapeutics, Inc. shareholders approved Approval of Charter Amendment to Effect a Reverse Stock Split at a ratio between 1:75 and 1:200, if and when determined by the Board at the 2026-05-08 meeting. - Proposal: reverse split - Outcome: passed - Meeting: 2026-05-08 source text: Proposal 7—Approval of Charter Amendment to Effect a Reverse Stock Split: Votes For Votes Against Abstentions 121,087,262 2,639,613 31,517 evidence_url: https://www.sec.gov/Archives/edgar/data/1563577/000119312526216710/0001193125-26-216710-index.htm - Shareholder Votes Galera Therapeutics, Inc. shareholders approved Approval of compensation paid to the Company’s named executive officers (Say-on-Pay) at the 2026-05-08 meeting. - Proposal: say on pay - Outcome: passed - Meeting: 2026-05-08 source text: Proposal 3—Say-on-Pay Vote: Votes For Votes Against Abstentions Broker Non-Votes 108,167,385 3,690,210 1,022,848 10,877,949 evidence_url: https://www.sec.gov/Archives/edgar/data/1563577/000119312526216710/0001193125-26-216710-index.htm This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.